全文获取类型
收费全文 | 7905篇 |
免费 | 612篇 |
国内免费 | 3篇 |
出版年
2023年 | 59篇 |
2022年 | 39篇 |
2021年 | 241篇 |
2020年 | 157篇 |
2019年 | 174篇 |
2018年 | 194篇 |
2017年 | 171篇 |
2016年 | 277篇 |
2015年 | 453篇 |
2014年 | 487篇 |
2013年 | 576篇 |
2012年 | 713篇 |
2011年 | 670篇 |
2010年 | 422篇 |
2009年 | 386篇 |
2008年 | 521篇 |
2007年 | 450篇 |
2006年 | 439篇 |
2005年 | 386篇 |
2004年 | 332篇 |
2003年 | 267篇 |
2002年 | 281篇 |
2001年 | 54篇 |
2000年 | 46篇 |
1999年 | 62篇 |
1998年 | 46篇 |
1997年 | 38篇 |
1996年 | 35篇 |
1995年 | 35篇 |
1994年 | 30篇 |
1993年 | 20篇 |
1992年 | 43篇 |
1991年 | 37篇 |
1990年 | 27篇 |
1989年 | 43篇 |
1988年 | 20篇 |
1987年 | 22篇 |
1986年 | 27篇 |
1985年 | 19篇 |
1984年 | 16篇 |
1983年 | 13篇 |
1982年 | 16篇 |
1981年 | 17篇 |
1980年 | 19篇 |
1979年 | 13篇 |
1978年 | 15篇 |
1977年 | 14篇 |
1976年 | 10篇 |
1973年 | 13篇 |
1972年 | 9篇 |
排序方式: 共有8520条查询结果,搜索用时 171 毫秒
1.
2.
3.
4.
5.
Nicolas Delaleu Heike Immervoll Janet Cornelius Roland Jonsson 《Arthritis research & therapy》2008,10(1):R22
Introduction
Sj?gren's syndrome (SS) is a systemic autoimmune disease that mainly targets the exocrine glands. The aim of this study was to investigate the involvement of 87 proteins measured in serum and 75 proteins analyzed in saliva in spontaneous experimental SS. In addition, we intended to compute a model of the immunological situation representing the overt disease stage of SS. 相似文献6.
7.
8.
9.
10.
Radwan H. Ahmed Hasniza Zaman Huri Zaid Al-Hamodi Sameer D. Salem Sekaran Muniandy 《PloS one》2015,10(10)
BackgroundA soluble form of CD26/dipeptidyl peptidase-IV (sCD26/DPP-IV) induces DPP-IV enzymatic activity that degrades incretin. We investigated fasting serum levels of sCD26/DPP-IV and active glucagon-like peptide-1 (GLP-1) in Malaysian patients with type 2 diabetes mellitus (T2DM) with and without metabolic syndrome (MetS), as well as the associations between sCD26/DPP-IV levels, MetS, and antidiabetic therapy.MethodsWe assessed sCD26/DPP-IV levels, active GLP-1 levels, body mass index (BMI), glucose, insulin, A1c, glucose homeostasis indices, and lipid profiles in 549 Malaysian subjects (including 257 T2DM patients with MetS, 57 T2DM patients without MetS, 71 non-diabetics with MetS, and 164 control subjects without diabetes or metabolic syndrome).ResultsFasting serum levels of sCD26/DPP-IV were significantly higher in T2DM patients with and without MetS than in normal subjects. Likewise, sCD26/DPP-IV levels were significantly higher in patients with T2DM and MetS than in non-diabetic patients with MetS. However, active GLP-1 levels were significantly lower in T2DM patients both with and without MetS than in normal subjects. In T2DM subjects, sCD26/DPP-IV levels were associated with significantly higher A1c levels, but were significantly lower in patients using monotherapy with metformin. In addition, no significant differences in sCD26/DPP-IV levels were found between diabetic subjects with and without MetS. Furthermore, sCD26/DPP-IV levels were negatively correlated with active GLP-1 levels in T2DM patients both with and without MetS. In normal subjects, sCD26/DPP-IV levels were associated with increased BMI, cholesterol, and LDL-cholesterol (LDL-c) levels.ConclusionSerum sCD26/DPP-IV levels increased in T2DM subjects with and without MetS. Active GLP-1 levels decreased in T2DM patients both with and without MetS. In addition, sCD26/DPP-IV levels were associated with Alc levels and negatively correlated with active GLP-1 levels. Moreover, metformin monotherapy was associated with reduced sCD26/DPP-IV levels. In normal subjects, sCD26/DPP-IV levels were associated with increased BMI, cholesterol, and LDL-c. 相似文献